Phase 2 trial data show gastrointestinal adverse events including nausea, vomiting, and upper abdominal discomfort are among the most common side effects, particularly at higher doses
When any of those slips, the result is usually minor and short-lived, but it is worth understanding what can actually go wrong, and why we think this is a job for a clinician rather than a kitchen-table DIY
Its hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that imitate the role of a hormone, GLP-1, that works to balance blood sugar and curb hunger, ultimately supporting weight loss) were absolutely everywhere
NHS specialists typically start at the lowest dose and build up slowly to balance results with comfort